CHEMINFORMATICS.ORG
Today's Pharma Headlines: Genentech seeks FDA approval for Venclexta for AML - Dermavant to buy rights to tapinarof from GSK for £250m - Genmab, Immatics to develop next-generation bispecific cancer immunotherapies - ...